Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
Objective. To describe the resistance profile and the genetic characteristics of Escherichia coli isolates that harbor the mobilizable colistin resistance gene mcr-1 in Argentina. Methods. This was a retrospective study of 192 E. coli isolates positive for mcr-1 obtained from 69 hospitals of Buenos...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pan American Health Organization
2020-09-01
|
Series: | Revista Panamericana de Salud Pública |
Subjects: | |
Online Access: | https://iris.paho.org/handle/10665.2/52324 |
id |
doaj-0ca7e4cc7efd48348704fa31841da1b6 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Diego Faccone Melina Rapoport Ezequiel Albornoz Federico Celaya Juan De Mendieta Denise De Belder Celeste Lucero Sonia Gomez Diego Danze Fernando Pasteran Alejandra Corso Mobilizable Colistin Resistance Group |
spellingShingle |
Diego Faccone Melina Rapoport Ezequiel Albornoz Federico Celaya Juan De Mendieta Denise De Belder Celeste Lucero Sonia Gomez Diego Danze Fernando Pasteran Alejandra Corso Mobilizable Colistin Resistance Group Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018 Revista Panamericana de Salud Pública drug resistance, multiple colistin enterobacteriaceae escherichia coli argentina |
author_facet |
Diego Faccone Melina Rapoport Ezequiel Albornoz Federico Celaya Juan De Mendieta Denise De Belder Celeste Lucero Sonia Gomez Diego Danze Fernando Pasteran Alejandra Corso Mobilizable Colistin Resistance Group |
author_sort |
Diego Faccone |
title |
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018 |
title_short |
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018 |
title_full |
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018 |
title_fullStr |
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018 |
title_full_unstemmed |
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018 |
title_sort |
plasmidic resistance to colistin mediated by mcr-1 gene in escherichia coli clinical isolates in argentina: a retrospective study, 2012–2018 |
publisher |
Pan American Health Organization |
series |
Revista Panamericana de Salud Pública |
issn |
1020-4989 1680-5348 |
publishDate |
2020-09-01 |
description |
Objective. To describe the resistance profile and the genetic characteristics of Escherichia coli isolates that harbor the mobilizable colistin resistance gene mcr-1 in Argentina.
Methods. This was a retrospective study of 192 E. coli isolates positive for mcr-1 obtained from 69 hospitals of Buenos Aires City and 14 Argentinean provinces in 2012 – 2018. The antimicrobial susceptibility was performed by agar diffusion, broth macrodilution, and/or agar dilution. Standard polymerase chain reaction (PCR) was performed to detect resistance genes and incompatibility groups; specific PCR was applied to discriminate between blaCTX-M allelic groups and mcr-1.5 variant. The genetic relatedness among isolates was evaluated by XbaI-pulsed field gel electrophoresis and multilocus sequence typing in a subset of isolates.
Results. All E. coli isolates showed minimal inhibitory concentrations to colistin ≥ 4μg/mL; nearly 50% were resistant to third-generation cephalosporins, with CTX-M-2 being the main extended-spectrum β-lactamase detected. Five E. coli were carbapenemase-producers (3 NDM, 2 KPC). The mcr-1.5 variant was detected in 13.5% of the isolates. No genetic relationship was observed among the mcr-1-positive E. coli clinical isolates, but a high proportion (164/192; 85.4%) of IncI2 plasmids was detected.
Conclusions. The presence of IncI2 plasmids among highly diverse E. coli clones suggests that the mcr-1 gene’s wide distribution in Argentina may be driven by the horizontal transmission of IncI2 plasmids. |
topic |
drug resistance, multiple colistin enterobacteriaceae escherichia coli argentina |
url |
https://iris.paho.org/handle/10665.2/52324 |
work_keys_str_mv |
AT diegofaccone plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT melinarapoport plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT ezequielalbornoz plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT federicocelaya plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT juandemendieta plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT denisedebelder plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT celestelucero plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT soniagomez plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT diegodanze plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT fernandopasteran plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT alejandracorso plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 AT mobilizablecolistinresistancegroup plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018 |
_version_ |
1724443265989607424 |
spelling |
doaj-0ca7e4cc7efd48348704fa31841da1b62020-11-25T04:02:22ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49891680-53482020-09-0144551810.26633/RPSP.2020.55rpspPlasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018Diego Faccone0Melina Rapoport1Ezequiel Albornoz2Federico Celaya3Juan De Mendieta4Denise De Belder5Celeste Lucero6Sonia Gomez7Diego Danze8Fernando Pasteran9Alejandra Corso10Mobilizable Colistin Resistance Group11Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.National Council on Scientific and Technical Research (CONICET), Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.National Council on Scientific and Technical Research (CONICET), Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Members are listed in the Acknowledgement at the end of the article.Objective. To describe the resistance profile and the genetic characteristics of Escherichia coli isolates that harbor the mobilizable colistin resistance gene mcr-1 in Argentina. Methods. This was a retrospective study of 192 E. coli isolates positive for mcr-1 obtained from 69 hospitals of Buenos Aires City and 14 Argentinean provinces in 2012 – 2018. The antimicrobial susceptibility was performed by agar diffusion, broth macrodilution, and/or agar dilution. Standard polymerase chain reaction (PCR) was performed to detect resistance genes and incompatibility groups; specific PCR was applied to discriminate between blaCTX-M allelic groups and mcr-1.5 variant. The genetic relatedness among isolates was evaluated by XbaI-pulsed field gel electrophoresis and multilocus sequence typing in a subset of isolates. Results. All E. coli isolates showed minimal inhibitory concentrations to colistin ≥ 4μg/mL; nearly 50% were resistant to third-generation cephalosporins, with CTX-M-2 being the main extended-spectrum β-lactamase detected. Five E. coli were carbapenemase-producers (3 NDM, 2 KPC). The mcr-1.5 variant was detected in 13.5% of the isolates. No genetic relationship was observed among the mcr-1-positive E. coli clinical isolates, but a high proportion (164/192; 85.4%) of IncI2 plasmids was detected. Conclusions. The presence of IncI2 plasmids among highly diverse E. coli clones suggests that the mcr-1 gene’s wide distribution in Argentina may be driven by the horizontal transmission of IncI2 plasmids.https://iris.paho.org/handle/10665.2/52324drug resistance, multiplecolistinenterobacteriaceaeescherichia coliargentina |